[Hepatic coma. Therapeutic aspects].
D000596:Amino Acids / Q000627:therapeutic use; D001971:Bromocriptine / Q000627:therapeutic use; D004573:Electrolytes / Q000378:metabolism; D005665:Furosemide / Q000627:therapeutic use; D005947:Glucose / Q000008:administration & dosage; D006501:Hepatic Encephalopathy / Q000628:therapy*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral; D007980:Levodopa / Q000627:therapeutic use; D009584:Nitrogen / Q000378:metabolism; D013148:Spironolactone / Q000627:therapeutic use; D014803:Vitamin B Complex / Q000008:administration & dosage
D000596:Amino Acids; D004573:Electrolytes; D006635:Histamine H2 Antagonists; D014803:Vitamin B Complex; D013148:Spironolactone; D001971:Bromocriptine; D007980:Levodopa; D005665:Furosemide; D005947:Glucose; D009584:Nitrogen
Il coma epatico. Aspetti terapeutici.